Pfizer Inc has approached Dublin-based generic drugmaker Actavis Plc to express its interest in an acquisition, Bloomberg reported, citing people with knowledge of the matter. The companies are not currently in formal talks and Pfizer has not made an offer, the Bloomberg report said. (bloom.bg/1uVW0QP)Pfizer in May abandoned its attempt to purchase British drugmaker AstraZeneca Plc for nearly 70 billion pounds ($118 billion).Actavis, which has a market capitalization of about $63 billion, obtained an Irish tax domicile by acquiring Warner Chilcott Plc last year.Tough new U.S. rules on corporate "inversions" on Tuesday sent a chill through the market for the tax-avoidance deals, both pending and potential.
Shares of ACT traded higher by 2.16% or $5.08/share to $240.70. In the past year, the shares have traded as low as $136.52 and as high as $245.50. On average, 2309410 shares of ACT exchange hands on a given day and today's volume is recorded at 4722368.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN fell by 4.63% or $-3.46/share to $71.21. In the past year, the shares have traded as low as $49.63 and as high as $82.68. On average, 2173080 shares of AZN exchange hands on a given day and today's volume is recorded at 6961286.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE fell by 0.48% or $-0.145/share to $30.04. In the past year, the shares have traded as low as $27.87 and as high as $32.96. On average, 23020800 shares of PFE exchange hands on a given day and today's volume is recorded at 22278436.
Source
